Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients

Published:2015-01-24 Issue:11 Volume:33 Page:1661-1667
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Langsenlehner Tanja,Thurner Eva-Maria,Krenn-Pilko Sabine,Langsenlehner Uwe,Stojakovic Tatjana,Gerger Armin,Pichler Martin

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-015-1494-7.pdf

Reference27 articles.

1. Castelli T, Cimino S, Magno C, Morgia G (2010) Molecular markers for prostatic cancer. Front Biosci (Elite Ed) 2:641–656

2. Huang HC, Zheng S, VanBuren V, Zhao Z (2010) Discovering disease-specific biomarker genes for cancer diagnosis and prognosis. Technol Cancer Res Treat 9:219–230

3. Balkwill F, Mantovani A (2001) Inflammation and cancer: Back to Virchow? Lancet 357:539–545

4. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

5. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444. doi: 10.1038/nature07205

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer;Cancers;2024-07-14

2. Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review;Asian Journal of Urology;2023-02

3. A vérképből meghatározott neutrophil-lymphocyta arány prognosztikai értéke daganatos betegségekben;Orvosi Hetilap;2022-07-03

4. The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy;Frontiers in Oncology;2022-06-02

5. Predicting the diagnosis of prostate cancer with a scoring system based on novel biomarkers;BMC Urology;2022-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3